Gene therapy for spinal muscular atrophy: the benefit–cost profile

Gene therapy for spinal muscular atrophy: the benefit–cost profile

Bibliographic Details
Format: Article
Language:English
Published: Elsevier 2021-07-01
Series:EClinicalMedicine
Online Access:http://www.sciencedirect.com/science/article/pii/S258953702100345X
id doaj-5959aedd098749a68e1aa3a0d542f19a
record_format Article
spelling doaj-5959aedd098749a68e1aa3a0d542f19a2021-07-29T04:23:39ZengElsevierEClinicalMedicine2589-53702021-07-0137101065Gene therapy for spinal muscular atrophy: the benefit–cost profilehttp://www.sciencedirect.com/science/article/pii/S258953702100345X
collection DOAJ
language English
format Article
sources DOAJ
title Gene therapy for spinal muscular atrophy: the benefit–cost profile
spellingShingle Gene therapy for spinal muscular atrophy: the benefit–cost profile
EClinicalMedicine
title_short Gene therapy for spinal muscular atrophy: the benefit–cost profile
title_full Gene therapy for spinal muscular atrophy: the benefit–cost profile
title_fullStr Gene therapy for spinal muscular atrophy: the benefit–cost profile
title_full_unstemmed Gene therapy for spinal muscular atrophy: the benefit–cost profile
title_sort gene therapy for spinal muscular atrophy: the benefit–cost profile
publisher Elsevier
series EClinicalMedicine
issn 2589-5370
publishDate 2021-07-01
url http://www.sciencedirect.com/science/article/pii/S258953702100345X
_version_ 1721259514104119296

Similar Items